Viewing data from:

PEPTAVLON

NDA

PENTAGASTRIN | N017048 | WYETH AYERST LABORATORIES

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

1 trial from ClinicalTrials.gov, 1 completed

Trial	Phase	Status	Sponsor	Enrollment	Dates
A New Method for Determining Gastric Acid Output Using a Wireless Capsule NCT00702533	—	Completed	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	80	2008-06-18

Source: ClinicalTrials.gov. Trials matched by ingredient name.

Products (1)

#001 — 0.25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RLD

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.